Low-dose interleukin-2 therapy in systemic lupus erythematosus

By sjmartinez • October 2, 2023

La Cava A. Low-dose interleukin-2 therapy in systemic lupus erythematosus. Rheumatol Immunol Res. 2023 Sep 27;4(3):150-156. doi: 10.2478/rir-2023-0021. PMID: 37781677; PMCID: PMC10538619.

Tags: interleukin-2, low-dose IL-2, Publications, Rheumatology, systemic lupus erythematosus, T regulatory cells

Genetic Research within Indigenous Communities: Engagement Opportunities and Pathways Forward

Barton KS, Porter KM, Mai T, Claw KG, Hiratsuka VY, Carroll SR, Burke W, Garrison NA. Genetic Research within Indigenous Communities: Engagement Opportunities and Pathways[...]

Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study

Rastogi A, Pollack CV Jr, Sánchez Lázaro IJ, Lesén E, Arnold M, Franzén S, Allum A, Hernández I, Murohara T, Kanda E. Maintained renin-angiotensin-aldosterone system[...]

A Tale of Two Islands – Leptospirosis in Strikingly Different Ecological Settings Reveals Pathogenomic Insights

Haake DA. A Tale of Two Islands - Leptospirosis in Strikingly Different Ecological Settings Reveals Pathogenomic Insights. Am J Trop Med Hyg. 2024 May 2:tpmd240254.[...]